ISSN: 2332-0877

感染症と治療ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Presumptive Diagnosis and Treatment of Malaria in Febrile Children in Parts of South Eastern Nigeria

Okoro CI, Chukwuocha UM, Nwakwuo GC and Ukaga CN

Background: Malaria treatment in Nigeria and other Sub-Saharan Africa is largely based on presumptive diagnosis leading to poor management of non-malaria febrile illness and abuse of antimalarial drugs.

Objectives: To evaluate malaria treatments based on presumptive diagnosis and describe the actual density of uncomplicated malaria among febrile children in South Eastern Nigeria.

Methods: Parasitological diagnosis using microscopy was done among 560 febrile children, 0-12 years attending Paediatric Clinics in a tertiary health facility in the study area. Their blood samples were collected prior to malaria treatment using IMCI guidelines and standard routine clinical practice. These children were grouped into under 5 years and 5-12 years. Data was analysed using SPSS.

Results: Out of 560 children (0-12 years) enrolled in this study, 156(27.9%) were positive for malaria parasites, while 404(72.1%) were negative. Children’s age was significantly related to the prevalence of uncomplicated malaria (p<0.05) and a high determinant in explaining 6.4% of the variance in the prevalence of uncomplicated malaria (F=37.915 and p<0.05). Children 5-12 years (51.9%) had higher parasite density (40,678.2 P/μl) compared to those less than 5. The negative result of 72.1% indicated possibility of overtreatment with antimalarial.

Conclusion: The findings highlight the need for the scaling-up of parasitological confirmation of all malaria suspected cases before treatment with the artemesinin-based combination therapies. Improving the diagnostic system for effective health care delivery in endemic areas will not only provide a good platform for malaria treatment/ monitoring but also reduce rapid onset of drug resistance.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。